Financial Statements · Financial Reporting

TRIZLEX BIOPHARMA OÜ

Official identifier 11220756Record date 31 Dec 2019
Estonia

Report

Legal form
OÜ
Report status
Registered

Dates

Reporting year
2019
Period start
1 Jan 2019
Submitted date
18 Oct 2020

Report

Consolidated
No
Audited
No

Financial metrics

StatementMetricValue
Balance sheetAssets75,153
Balance sheetCash and cash equivalents11,511
Balance sheetCurrent assets75,153
Balance sheetCurrent liabilities5,900
Balance sheetEquity69,253
Balance sheetShare capital at nominal value2,556
Balance sheetNon-current assets0
Balance sheetRetained earnings (loss) from previous periods16,156
Income statement scheme 1Depreciation and impairment of non-current assets0
Income statement scheme 1Labour costs0
Income statement scheme 1Revenue192,893
Income statement scheme 1Annual period profit / loss50,541
Income statement scheme 1Operating profit (loss)50,541
Income statement scheme 1Profit (loss) before income tax50,541
Profit distribution proposalRetained earnings (loss) from previous periods16,156
Note: Labour costsEmployees1
Note: Labour costsLabour costs5,967

Linked company

Company: TRIZLEX BIOPHARMA OÜ

Source

Estonian e-Business Register Annual Reports open data

View published source

Back to Financial Statements